Clinical Trial Update: A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS [Phase 2]

View source ↗

Summary

Phase 2 trial investigating itraconazole for treatment and prevention of histoplasmosis in patients with AIDS has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Histoplasmosis

Drugs mentioned

• Itraconazole (Itraconazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Histoplasmosis | Phase 2 | Status: COMPLETED